These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 25161101

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
    O'Neill PM, Rawe SL, Borstnik K, Miller A, Ward SA, Bray PG, Davies J, Oh CH, Posner GH.
    Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
    [Abstract] [Full Text] [Related]

  • 3. Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins.
    Xie SC, Dogovski C, Hanssen E, Chiu F, Yang T, Crespo MP, Stafford C, Batinovic S, Teguh S, Charman S, Klonis N, Tilley L.
    J Cell Sci; 2016 Jan 15; 129(2):406-16. PubMed ID: 26675237
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A better resolution for integrating methods for monitoring Plasmodium falciparum resistance to antimalarial drugs.
    Abdul-Ghani R, Al-Maktari MT, Al-Shibani LA, Allam AF.
    Acta Trop; 2014 Sep 15; 137():44-57. PubMed ID: 24801884
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6.
    Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O.
    Lancet; 2005 Dec 03; 366(9501):1960-3. PubMed ID: 16325698
    [Abstract] [Full Text] [Related]

  • 10. Alternative methods for the Plasmodium falciparum artemisinin ring-stage survival assay with increased simplicity and parasite stage-specificity.
    Kite WA, Melendez-Muniz VA, Moraes Barros RR, Wellems TE, Sá JM.
    Malar J; 2016 Feb 17; 15():94. PubMed ID: 26888201
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro sensitivity pattern of chloroquine and artemisinin in Plasmodium falciparum.
    Sharma S, Kaitholia K, Mishra N, Srivastava B, Pillai CR, Valecha N, Anvikar AR.
    Indian J Med Microbiol; 2016 Feb 17; 34(4):509-512. PubMed ID: 27934832
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of artemisone compared with artesunate against Plasmodium falciparum.
    Ramharter M, Burkhardt D, Nemeth J, Adegnika AA, Kremsner PG.
    Am J Trop Med Hyg; 2006 Oct 17; 75(4):637-9. PubMed ID: 17038685
    [Abstract] [Full Text] [Related]

  • 14. Stage specific activity of synthetic antimalarial endoperoxides, N-89 and N-251, against Plasmodium falciparum.
    Morita M, Koyama T, Sanai H, Sato A, Hiramoto A, Masuyama A, Nojima M, Wataya Y, Kim HS.
    Parasitol Int; 2015 Feb 17; 64(1):113-7. PubMed ID: 25449979
    [Abstract] [Full Text] [Related]

  • 15. Screening and evaluation of inhibitors of Plasmodium falciparum merozoite egress and invasion using cytometry.
    Bouillon A, Gorgette O, Mercereau-Puijalon O, Barale JC.
    Methods Mol Biol; 2013 Feb 17; 923():523-34. PubMed ID: 22990802
    [Abstract] [Full Text] [Related]

  • 16. Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.
    Kaddouri H, Nakache S, Houzé S, Mentré F, Le Bras J.
    Antimicrob Agents Chemother; 2006 Oct 17; 50(10):3343-9. PubMed ID: 17005815
    [Abstract] [Full Text] [Related]

  • 17. Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
    Wilson DW, Langer C, Goodman CD, McFadden GI, Beeson JG.
    Antimicrob Agents Chemother; 2013 Mar 17; 57(3):1455-67. PubMed ID: 23318799
    [Abstract] [Full Text] [Related]

  • 18. Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites.
    Ouji M, Nguyen M, Mustière R, Jimenez T, Augereau JM, Benoit-Vical F, Deraeve C.
    Bioorg Med Chem Lett; 2021 May 01; 39():127884. PubMed ID: 33636304
    [Abstract] [Full Text] [Related]

  • 19. A Novel Antiparasitic Compound Kills Ring-Stage Plasmodium falciparum and Retains Activity Against Artemisinin-Resistant Parasites.
    Clements RL, Streva V, Dumoulin P, Huang W, Owens E, Raj DK, Burleigh B, Llinás M, Winzeler EA, Zhang Q, Dvorin JD.
    J Infect Dis; 2020 Mar 02; 221(6):956-962. PubMed ID: 31616928
    [Abstract] [Full Text] [Related]

  • 20. Phenotypic changes in artemisinin-resistant Plasmodium falciparum lines in vitro: evidence for decreased sensitivity to dormancy and growth inhibition.
    Teuscher F, Chen N, Kyle DE, Gatton ML, Cheng Q.
    Antimicrob Agents Chemother; 2012 Jan 02; 56(1):428-31. PubMed ID: 21986828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.